Mayne Pharma losses blow out to $317 million
Salisbury pharmaceutical company Mayne Pharma has seen its losses worsen by almost $100 million after a financial year of “significant change”.
Source: indaily.com.au
Stay updated with breaking news from Shawn Patrick Obrien. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Salisbury pharmaceutical company Mayne Pharma has seen its losses worsen by almost $100 million after a financial year of “significant change”.
The share price of ASX 300 stock Mayne Pharma Group Ltd (ASX: MYX) has soared since the company posted earnings on Tuesday morning.